FAST-RPP

Respiratory Panel

shutterstock_23581822+SMALL+%281%29.jpg

Upper Respiratory testing by molecular technique

Patients with respiratory infection symptoms who are at risk for complications may need a respiratory pathogens panel (RPP). Samples are taken from patients using a nasopharyngeal swab or nasal aspirate. With the rising threat of COVID-19 and other respiratory diseases, accurate pathogen detection is critical.

Our molecular diagnostic testing uses quantitative polymerase chain reaction (qPCR) to identify various forms of acute respiratory tract infections (ARTI). Our RPP screens 45 targets with an overall sensitivity of 95% and specificity of 99%. This level of rapid and accurate detection of respiratory pathogens helps clinicians determine a patient’s need for antibiotic or antiviral therapy.

 

Respiratory Testing Panels

BACTERIAL TARGETS

Pneumonia Panel

  • Chlamydia pneumoniae

  • Streptococcus pneumoniae

  • Klebsiella pneumoniae

  • Haemophilus influenzae

  • Legionella pneumophila

  • Moraxella Catarrhalis

  • Bordetella pertusis (whooping cough)

  • Bordetella pan

  • Bordetella holmesii

  • Staphylococcus aureus

  • MRSA

FUNGAL TARGETS

  • Pneumocystis Jirovecii

VIRAL TARGETS

Influenza Panel

  • Influenza (A Pan, H1N1, H3N2)

  • Influenza B Pan

  • Parainfluenza (1, 2, 3, 4)

Common Cold Panel

  • Adenovirus 1 and 2 Alpha

  • Adenovirus 1 and 2 Beta

  • Human Bocavirus

  • Coronavirus (229E, HKU1, NL63, OC43)

  • Enterovirus Pan

  • Enterovirus D68

  • Human Rhinovirus 1

  • Human Rhinovirus 2

  • Human Parechovirus

Respiratory Syncytial Virus A/B

Human Metapneumovirus

SARS (Severe Acute Resp Syndrome)

MERS (Middle East Resp Syndrome)

  • Varicella-zoster Virus

  • Epsetin-Barr Virus

  • Cytomegalovirus

  • Human Herpesvirus 6

  • Measles

  • Mumps

COVID-19

  • SARS-COV-2